| Revenue | 56.74a | 53.07a |
| Imbalance cost pass-through (ICPT) under recovery | 9.1a | 10.6a |
| Operating expenses | -58.96a | -57.37a |
| Net reversal on impairment of financial instruments | 0.79a | 0.11a |
| Other operating income | 1.05a | 0.95a |
| Operating profit | 8.72a | 7.36a |
| Foreign exchange gain/(loss) | 0.47a | -0.21a |
| Share of results of joint ventures | 0.02a | 0.02a |
| Share of results of associates | 0.08a | 0.04a |
| Profit before finance cost | 9.3a | 7.21a |
| Finance income | 0.63a | 0.54a |
| Finance cost | -4.1a | -4.33a |
| Fair value changes of financial instruments | -0.01a | -0.05a |
| Profit before taxation and zakat | 5.81a | 3.37a |
| Taxation and zakat | -1.09a | -0.77a |
| Profit for the financial year | 4.73a | 2.6a |
| Profit attributable to: | — | — |
| Owners of the company | 4.7a | 2.77a |
| Non-controlling interests | 0.03a | -0.17a |